Lv1
24 积分 2024-04-21 加入
The hallmarks of cancer immune evasion
20天前
已完结
Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways
24天前
已完结
Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer
24天前
已完结
Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
2个月前
已完结
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
2个月前
已完结
Age-related decline in CD8+ tissue resident memory T cells compromises antitumor immunity
2个月前
已完结
The aged tumor microenvironment limits T cell control of cancer
2个月前
已完结
Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation
2个月前
已完结
Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway
2个月前
已完结
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
2个月前
已完结
皖公网安备34019202002308
